Northwestern Mutual Wealth Management’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-270
| Closed | -$397 | – | 3833 |
|
|
2025
Q1 | $397 | Hold |
270
| – | – | ﹤0.01% | 3394 |
|
|
2024
Q4 | $1.2K | Hold |
270
| – | – | ﹤0.01% | 3270 |
|
|
2024
Q3 | $1.11K | Hold |
270
| – | – | ﹤0.01% | 3225 |
|
|
2024
Q2 | $1.76K | Sell |
270
-20
| -7% | -$141 | ﹤0.01% | 3128 |
|
|
2024
Q1 | $2.53K | Hold |
290
| – | – | ﹤0.01% | 3003 |
|
|
2023
Q4 | $3.32K | Buy |
290
+20
| +7% | +$198 | ﹤0.01% | 2971 |
|
|
2023
Q3 | $2.6K | Hold |
270
| – | – | ﹤0.01% | 2910 |
|
|
2023
Q2 | $2.87K | Sell |
270
-7,000
| -96% | -$75.2K | ﹤0.01% | 2914 |
|
|
2023
Q1 | $76.5K | Buy |
7,270
+7,000
| +2,593% | +$78.4K | ﹤0.01% | 1790 |
|
|
2022
Q4 | $3.35K | Hold |
270
| – | – | ﹤0.01% | 2831 |
|
|
2022
Q3 | $3K | Hold |
270
| – | – | ﹤0.01% | 2799 |
|
|
2022
Q2 | $3K | Sell |
270
-1,000
| -79% | -$11.8K | ﹤0.01% | 2844 |
|
|
2022
Q1 | $16K | Hold |
1,270
| – | – | ﹤0.01% | 2392 |
|
|
2021
Q4 | $15K | Hold |
1,270
| – | – | ﹤0.01% | 2438 |
|
|
2021
Q3 | $17K | Hold |
1,270
| – | – | ﹤0.01% | 2280 |
|
|
2021
Q2 | $16K | Hold |
1,270
| – | – | ﹤0.01% | 2285 |
|
|
2021
Q1 | $14K | Hold |
1,270
| – | – | ﹤0.01% | 2181 |
|
|
2020
Q4 | $14K | Hold |
1,270
| – | – | ﹤0.01% | 2082 |
|
|
2020
Q3 | $11K | Hold |
1,270
| – | – | ﹤0.01% | 1962 |
|
|
2020
Q2 | $13K | Sell |
1,270
-95
| -7% | -$972 | ﹤0.01% | 1835 |
|
|
2020
Q1 | $14K | Hold |
1,365
| – | – | ﹤0.01% | 1804 |
|
|
2019
Q4 | $18K | Buy |
1,365
+95
| +7% | +$1.05K | ﹤0.01% | 1768 |
|
|
2019
Q3 | $11K | Hold |
1,270
| – | – | ﹤0.01% | 1901 |
|
|
2019
Q2 | $14K | Sell |
1,270
-297
| -19% | -$3.33K | ﹤0.01% | 1847 |
|
|
2019
Q1 | $18K | Buy |
1,567
+1,194
| +320% | +$13.3K | ﹤0.01% | 1761 |
|
|
2018
Q4 | $3K | Buy |
373
+51
| +16% | +$585 | ﹤0.01% | 2131 |
|
|
2018
Q3 | $5K | Hold |
322
| – | – | ﹤0.01% | 2102 |
|
|
2018
Q2 | $5K | Hold |
322
| – | – | ﹤0.01% | 2012 |
|
|
2018
Q1 | $4K | Hold |
322
| – | – | ﹤0.01% | 1945 |
|
|
2017
Q4 | $4K | Hold |
322
| – | – | ﹤0.01% | 1974 |
|
|
2017
Q3 | $4K | Buy |
+322
| New | +$4.43K | ﹤0.01% | 1861 |
|
|
2017
Q1 | – | Sell |
-202
| Closed | -$3K | – | 2204 |
|
|
2016
Q4 | $3K | Buy |
+202
| New | +$2.55K | ﹤0.01% | 1967 |
|
|
2016
Q3 | – | Sell |
-177
| Closed | -$2K | – | 844 |
|
|
2016
Q2 | $2K | Hold |
177
| – | – | ﹤0.01% | 1840 |
|
|
2016
Q1 | $2K | Buy |
+177
| New | +$1.46K | ﹤0.01% | 1892 |
|
Other funds holding IRWD
AC
SCM
KCM
Northwestern Mutual Wealth Management's IRWD Position: Q2 2025 in Review
Northwestern Mutual Wealth Management sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2025, closing a stake of 270 shares — an estimated $397 sold.
Northwestern Mutual Wealth Management first reported a position in IRWD in Q1 2016 and held it in 34 quarters. The position peaked at $76.5K in Q1 2023. 155 funds tracked by Wall St. Rank hold IRWD as of Q2 2025.
- Northwestern Mutual Wealth Management reported no remaining Ironwood Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
- Northwestern Mutual Wealth Management sold 270 Ironwood Pharmaceuticals shares in Q2 2025, an estimated $397.
- Northwestern Mutual Wealth Management first reported a position in Ironwood Pharmaceuticals in Q1 2016 and held it in 34 quarters.
- Northwestern Mutual Wealth Management's Ironwood Pharmaceuticals position peaked at $76.5K in Q1 2023.
- 155 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2025.
Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2025, filed 13 Aug 2025.